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The TAUSA trial is a multicenter randomized, double 
blinded study of thrombolysis and 
unstable angina. 
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In the pilot study 73 pts were 
to either intracoronary urokinsse (150,000 
or placebo immediately before angioplasty for 
table angina vith recent rest pain. The primary 
iographic end points vere the incidence of possible 
or definite (D) filling defects, indicative of 
thrombus 1 minute and 13 minutes folloving angioplasty. 
All pts vere pretreated vith ASA and 10,000 U of 
intravenous heparin. 
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The incidence of filling defects increased at 15 minutes 
after angioplasty. In 13 of the 16 vessels (81%) new 
filling defects appeared only on delayed views (15 
minutes). Redilation and/or thrombolytic therapy were 
required in 7 of 9 with definite filling defects. None 
of those redilated had an adverse in-hospital outcome. 
s previously reported, the incidence of filling defects 
1~0 decreased significantly vith the use of urokinase. 
In conclusion, delayed vievs folloving angioplasty in 
;;;JZ:~ angina are important for detecting filling 
l If this trend is corroborated by the larger 
TAUSA trial. delayed vievs may become standard procedure 
folloving wioplasty for all pts vith unstable angina. 
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